4
Changes in Ownership
Keros Therapeutics, Inc. Filed Acc 0001221590-26-000002
Director bought 2,000 shares at $11.21 ($22,420)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BIENAIME JEAN JACQUES Director | 2026-03-09 | Purchase 10b5-1 | +2,000 | $11.21 | $22,420 | 7,450 | D |
| Open-market purchases · 2,000 sh · avg $11.21 · $22,420 | |||||||
Loading xslF345X05/form4-03112026_080355.xml…